Melbourne, Victoria, Australia – 10 November 2017
Trajan Scientific and Medical (Trajan), is pleased to announce the appointment of Mr. John O’Connor as CEO of the organization from Monday 13 November 2017. Founder and current CEO Mr. Stephen Tomisich will transition to the role of Executive Chair, and says, “Having John step into the role of CEO prepares us for the next stage of Trajan’s growth.”
John has been an advisor to the Trajan Board over the past year, and has gained an intimate working knowledge of the company and its potential. Bringing over 25 years of global business experience as a Director and CEO in organizations ranging in size and scope from $10M to $1B in annual revenues, and has demonstrated an impressive track record of overseeing enterprises to realize their potential.
Photo (L-R): John O'Connor and Stephen Tomisich.
John says, “It is a privilege to be joining Trajan as the CEO and being able to contribute to the company’s impressive and ongoing growth path. I look forward to working with the entire Trajan team around the world, in continuing to deliver outstanding value to all of our stakeholders.”
Over its first six years Trajan has built a global organization of nearly 400 staff, refreshed and renewed the infrastructure of the operations acquired, and developed through collaboration a deep technology pipeline ready for commercial translation in the coming years.
Stephen is enthusiastic about the future, “This is an exciting time for Trajan as we continue our drive to impact the world through science that benefits people.”
Photo (L-R):John O'Connor and Stephen Tomisich at Trajan Global Corporate Headquarters, Melbourne, Australia.
Press release [PDF]
Media contact information
Trajan Scientific and Medical
Tel: +44 (0) 1244 403 100